KLT-17089-52642
4 vaccinations
6 coded responses
41 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 010 / MA
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Oedema peripheral — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to workFree text: Axillary swelling/painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Tenderness — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Axillary tenderness on side of vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite, Tenderness — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work or attend schoolFree text: Axillary tenderness, poor appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Hyperhidrosis, Oedema peripheral, Tenderness — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaFree text: Increased sweating, axillary tenderness/swellingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-12-29
- 2022-03-30
-
2022-09-14
Dose 4 — Pfizer-BioNTech
- 2022-09-29
- 2022-10-14
- 2022-10-19
- 2022-10-26
-
2022-12-14
Survey response — 3 months, dose 4MedDRA: Ear infection, Sinusitis, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tinnitus and likely ear infection or sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-15
-
2023-03-15
Survey response — 6 months, dose 4MedDRA: Ear pain, Hypoacusis, Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-15
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-16
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | No |
Call center
4 call center cases
2 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary swelling/pain
Systemic reaction (other): Axillary tenderness on side of vaccine
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary tenderness, poor appetite
Systemic reaction (other): Increased sweating, axillary tenderness/swelling
Release 12 — 3 months, dose 4
Symptoms: Tinnitus and likely ear infection or sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear infection | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Hypoacusis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release